Is Exagen Inc. overvalued?

Exagen Inc. (XGN) — key valuation metrics and fundamentals.

No verdict

Price

$4.13

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$105.4M

Dividend yield

0.0%

Return on equity

-125.6%

Sector

Healthcare

See the full interactive analysis →

Fair value compares XGN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.